We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£890.00
It has never been this cheap. We have no record of a lower price.
£890 today · cheaper than every other day in the last 3 months
The 2027-2032 World Outlook for Human and Animal Vaccine Adjuvants
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 30 days · 30 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 30 days • 1 price levels
Price Analysis
Most common price: £890 (30 days, 100.0%)
Price range: £890 - £890
Price levels: 1 different prices over 30 days
Product Specifications
- Format
- paperback
- ASIN
- B0GMRR3W6K
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 05 January 2026
- Listed Since
- 10 February 2026
Similar Products You Might Like
The 2027-2032 World Outlook for Vaccine Adjuvants
The 2027-2032 World Outlook for Veterinary Vaccine Adjuvants
The 2027-2032 World Outlook for Particulate Vaccine Adjuvants
The 2026-2031 World Outlook for Human and Animal Vaccine Adjuvants
The 2027-2032 World Outlook for DNA Vaccines
The 2027-2032 World Outlook for Potential Analysis of Human DNA Vaccines
The 2027-2032 World Outlook for Zika Virus Vaccines
The 2026-2031 World Outlook for Veterinary Vaccine Adjuvants
The 2026-2031 World Outlook for Vaccine Adjuvants
The 2027-2032 World Outlook for H1N1 (Swine Flu) Vaccination
The 2027-2032 World Outlook for Interleukin Inhibitors
The 2027-2032 World Outlook for Antidotes
The 2027-2032 World Outlook for Oligonucleotide Therapeutics
The 2027-2032 World Outlook for Biotherapeutics Cell Line Developments
The 2027-2032 World Outlook for Combination Antibody Therapies
The 2027-2032 World Outlook for Biosurfactants
The 2027-2032 World Outlook for HIV Therapeutics
The 2027-2032 World Outlook for Speciality Fertilizers
The 2027-2032 World Outlook for Influenza
The 2027-2032 World Outlook for Hydroxychloroquine Sulphates
The 2027-2032 World Outlook for Animal Blood Plasma Products and Derivatives
The 2027-2032 World Outlook for Blood and Tissue Interferon Growth Factors
The 2027-2032 World Outlook for Biotherapeutics Cell Line Transfection and Selection
